Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnathan M Lancaster

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
American Journal of Obstetrics and Gynecology|May 7, 2010
Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicinMegan D Indermaur, Yin Xiong, Siddharth G Kamath, et al.
Journal of the Society for Gynecologic Investigation|January 7, 2004
Gene expression patterns that characterize advanced stage serous ovarian cancersJohnathan M Lancaster, Holly K Dressman, Regina S Whitaker, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2021
Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (<i>ATM</i>) Gene are Associated with High and Moderate Risks for Multiple CancersMichael J Hall, Ryan Bernhisel, Elisha Hughes, et al.
Journal of the Society for Gynecologic Investigation|September 13, 2003
Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancerRobert M Wenham, Brian Calingaert, Shazia Ali, et al.
Gynecologic Oncology|May 24, 2008
MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesisTodd Boren, Yin Xiong, Ardeshir Hakam, et al.
Gynecologic Oncology|February 25, 2009
MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapyTodd Boren, Yin Xiong, Ardeshir Hakam, et al.
American Journal of Obstetrics and Gynecology|March 20, 2013
Factors associated with improved toxicity and tolerability of intraperitoneal chemotherapy in advanced-stage epithelial ovarian cancersPatrick Teefey, Nadim Bou Zgheib, Sachin M Apte, et al.
American Journal of Obstetrics and Gynecology|January 22, 2018
Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancerBernadette M Boac, Yin Xiong, Sachin M Apte, et al.
International Journal of Cancer|August 13, 2015
STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancerJennifer Permuth-Wey, William J Fulp, Brett M Reid, et al.
Oncology Letters|February 13, 2016
Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancerNadim Bou Zgheib, Douglas C Marchion, Stephen H Bush, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
American Journal of Obstetrics and Gynecology|May 7, 2010
Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicinMegan D Indermaur, Yin Xiong, Siddharth G Kamath, et al.
Journal of the Society for Gynecologic Investigation|January 7, 2004
Gene expression patterns that characterize advanced stage serous ovarian cancersJohnathan M Lancaster, Holly K Dressman, Regina S Whitaker, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2021
Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (<i>ATM</i>) Gene are Associated with High and Moderate Risks for Multiple CancersMichael J Hall, Ryan Bernhisel, Elisha Hughes, et al.
Journal of the Society for Gynecologic Investigation|September 13, 2003
Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancerRobert M Wenham, Brian Calingaert, Shazia Ali, et al.
Gynecologic Oncology|May 24, 2008
MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesisTodd Boren, Yin Xiong, Ardeshir Hakam, et al.
Gynecologic Oncology|February 25, 2009
MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapyTodd Boren, Yin Xiong, Ardeshir Hakam, et al.
American Journal of Obstetrics and Gynecology|March 20, 2013
Factors associated with improved toxicity and tolerability of intraperitoneal chemotherapy in advanced-stage epithelial ovarian cancersPatrick Teefey, Nadim Bou Zgheib, Sachin M Apte, et al.
American Journal of Obstetrics and Gynecology|January 22, 2018
Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancerBernadette M Boac, Yin Xiong, Sachin M Apte, et al.
International Journal of Cancer|August 13, 2015
STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancerJennifer Permuth-Wey, William J Fulp, Brett M Reid, et al.
Oncology Letters|February 13, 2016
Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancerNadim Bou Zgheib, Douglas C Marchion, Stephen H Bush, et al.
Pageof 8